Prevalence and Factors Associated with Potassium Abnormalities Among Outpatients with Heart Failure Taking Diuretics in a Tertiary Referral Hospital in Tanzania.
Journal
The East African health research journal
ISSN: 2520-5285
Titre abrégé: East Afr Health Res J
Pays: Burundi
ID NLM: 101713200
Informations de publication
Date de publication:
2024
2024
Historique:
received:
10
04
2023
accepted:
04
03
2024
medline:
5
9
2024
pubmed:
5
9
2024
entrez:
5
9
2024
Statut:
ppublish
Résumé
Heart failure (HF) is a chronic progressive condition in which the heart is unable to pump enough blood to meet the body's need for blood and oxygen. Globally, about 64 million people are affected with HF. This study was undertaken to determine the magnitude and factors associated with potassium abnormalities in heart failure patients on diuretics in Tanzania. This was a hospital based cross-sectional study conducted at Bugando Medical Centre's outpatient clinic. The selection of this hospital was driven by the significant presence of heart failure patients in the facility and the convenience for the researchers, who were stationed at this facility during the study period. All consenting adult patients aged 18 years and above that were attending the cardiac clinic and had met Framingham criteria for heart failure and were taking diuretics for at least one month were included. The prevalence of hypokalemia and hyperkalemia was found to be 4.3% And 19.3% respectively. The median (IQR) age was 61 (46-70) years and majority of them (52.8%) were females. most of the patients (87.7%) had New York Heart Association (NYHA) class III heart failure. Factors associated with potassium abnormalities include medication use, kidney disease and more severe heart failure. Healthcare providers should ensure that all patients with these associated factors receive regular electrolyte testing. Electrolytes should be part of the baseline investigation to all patients with heart failure starting treatment, and should be closely monitored in every clinic visit for early detection of these abnormalities and possible intervention, including dose adjustments.
Sections du résumé
Background
UNASSIGNED
Heart failure (HF) is a chronic progressive condition in which the heart is unable to pump enough blood to meet the body's need for blood and oxygen. Globally, about 64 million people are affected with HF. This study was undertaken to determine the magnitude and factors associated with potassium abnormalities in heart failure patients on diuretics in Tanzania.
Methods
UNASSIGNED
This was a hospital based cross-sectional study conducted at Bugando Medical Centre's outpatient clinic. The selection of this hospital was driven by the significant presence of heart failure patients in the facility and the convenience for the researchers, who were stationed at this facility during the study period. All consenting adult patients aged 18 years and above that were attending the cardiac clinic and had met Framingham criteria for heart failure and were taking diuretics for at least one month were included.
Results
UNASSIGNED
The prevalence of hypokalemia and hyperkalemia was found to be 4.3% And 19.3% respectively. The median (IQR) age was 61 (46-70) years and majority of them (52.8%) were females. most of the patients (87.7%) had New York Heart Association (NYHA) class III heart failure.
Conclusion
UNASSIGNED
Factors associated with potassium abnormalities include medication use, kidney disease and more severe heart failure. Healthcare providers should ensure that all patients with these associated factors receive regular electrolyte testing. Electrolytes should be part of the baseline investigation to all patients with heart failure starting treatment, and should be closely monitored in every clinic visit for early detection of these abnormalities and possible intervention, including dose adjustments.
Identifiants
pubmed: 39234354
doi: 10.24248/eahrj.v8i1.759
pii: eahrj.v8i1.759
pmc: PMC11371019
doi:
Types de publication
Journal Article
Langues
eng
Pagination
142-147Informations de copyright
© The East African Health Research Commission 2024.